Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol

Rugo, HS, Cortes, J, Awada, A et al. (12 more authors) (2018) Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. Clinical Cancer Research, 24 (14). pp. 3348-3357. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
  • Rugo, HS
  • Cortes, J
  • Awada, A
  • O'Shaughnessy, J
  • Twelves, C
  • Im, S-A
  • Hannah, A
  • Lu, L
  • Sy, S
  • Caygill, K
  • Zajchowski, DA
  • Davis, DW
  • Tagliaferri, M
  • Hoch, U
  • Perez, EA
Dates:
  • Accepted: 26 March 2018
  • Published (online): 4 April 2018
  • Published: July 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Jul 2019 15:20
Last Modified: 11 Jul 2019 15:20
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1078-0432.CCR-17-3059
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics